Inaugural life science conference coming in May


A collection of life science sector leaders will participate in inaugural Delaware’s DNA: 2023 Life Science Conference on Thursday, May 11.

The event, hosted by the Delaware BioScience Association (Delaware Bio), will bring together regional and national biomedical researchers, business leaders, investors and policymakers for a day-long program of  panel discussions and expert speakers on industry issues.

Conference headliners include Delaware Gov.  John Carney, Incyte CEO Hervé Hoppenot, Biotechnology Innovation Organization (BIO) interim CEO Rachel King, Aisling Capital founder Dennis Purcell, National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Director Kelvin Lee, Prelude Therapeutics CEO Kris Vaddi and Eric Kmiec, director of the Gene Editing Institute, and founder of CorriXR Therapeutics.

“Delaware’s emerging posture as a global life science leader is clear and exciting,” said Michael Fleming, president of Delaware Bio. “Delaware’s DNA will shine a bright light on the full breadth and diversity of our unique strengths and rapid growth, while exploring the continued focus and investment required to ensure our future impact and success.”

Event topics

  • An inside perspective on the state of the industry from leading industry analysts and investors
  • Key issues in economic and workforce development
  • The regional potential for advanced and biopharmaceutical manufacturing
  • Advances and innovations in cancer research and treatment
  • Most promising new company

Competition and scientific poster presentations

 New this year, Delaware’s DNA will feature new life science businesses vying for the title of “Most Promising New Company.” Companies launched within the last five years are invited to apply to be among those selected to make five-minute pitches during a full session of conference participants. All event attendees will be eligible to vote on their favorite new companies via an app developed for the conference

Companies selected to participate will receive complimentary access to the conference and gain  exposure to the state’s  influential industry audience. Top vote winners will also be recognized with prizes and invited to share their stories at future Delaware Bio programs.

Another element of Delaware’s DNA will be poster presentations on science by local researchers. Throughout the conference, students and faculty of area educational and biomedical research institutions will be on hand to share and discuss their work with attendees. A call for proposals for the poster presentations and the most promising new company applications will be issued.


  • Avantor, delivered by VWR
  • ANP Technologies
  • Biotechnology Innovation Organization (BIO)
  • Choice MedWaste
  • Delaware Biotechnology Institute
  • Delaware Business Times
  • Delaware Prosperity Partnership
  • Facility Logix
  • Incyte
  • National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
  • Prelude Therapeutics
  • University of Delaware

For conference agenda details, information on sponsorship, and to purchase tickets, go to: